<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><!--The publisher of this article does not allow downloading of the full text in XML form.--><front><journal-meta><journal-id journal-id-type="nlm-ta">J Subst Use Addict Treat</journal-id><journal-id journal-id-type="iso-abbrev">J Subst Use Addict Treat</journal-id><journal-id journal-id-type="pmc-domain-id">319</journal-id><journal-id journal-id-type="pmc-domain">nihpa</journal-id><journal-title-group><journal-title>Journal of substance use and addiction treatment</journal-title></journal-title-group><issn pub-type="ppub">2949-8767</issn><issn pub-type="epub">2949-8759</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>NIHPA Author Manuscripts</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC11522973</article-id><article-id pub-id-type="pmcid-ver">PMC11522973.1</article-id><article-id pub-id-type="pmcaid">11522973</article-id><article-id pub-id-type="pmcaiid">11522973</article-id><article-id pub-id-type="manuscript-id">NIHMS2028715</article-id><article-id pub-id-type="pmid">38097045</article-id><article-id pub-id-type="doi">10.1016/j.josat.2023.209269</article-id><article-id pub-id-type="manuscript-id-alternative">NIHMS2028715</article-id><article-id pub-id-type="manuscript-id-alternative">NIHPA2028715</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Co-occurring substance use disorders among patients with opioid use disorder in rural primary care clinics</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Zhu</surname><given-names initials="Y">Yuhui</given-names></name><xref rid="A1" ref-type="aff">a</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Baldwin</surname><given-names initials="LM">Laura-Mae</given-names></name><xref rid="A2" ref-type="aff">b</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Mooney</surname><given-names initials="LJ">Larissa J.</given-names></name><xref rid="A1" ref-type="aff">a</xref><xref rid="A3" ref-type="aff">c</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Saxon</surname><given-names initials="AJ">Andrew J.</given-names></name><xref rid="A4" ref-type="aff">d</xref><xref rid="A5" ref-type="aff">e</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Kan</surname><given-names initials="E">Emily</given-names></name><xref rid="A1" ref-type="aff">a</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Hser</surname><given-names initials="YI">Yih-Ing</given-names></name><xref rid="A1" ref-type="aff">a</xref><xref rid="CR1" ref-type="corresp">*</xref></contrib></contrib-group><aff id="A1"><label>a</label> Department of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles, CA 90024, United States of America</aff><aff id="A2"><label>b</label> Department of Family Medicine, University of Washington, Seattle, WA 98195, United States of America</aff><aff id="A3"><label>c</label> Veterans Affairs Greater Los Angeles Healthcare System, Los Angeles, CA 90073, United States of America</aff><aff id="A4"><label>d</label> Center of Excellence in Substance Addiction Treatment and Education, Veterans Affairs Puget Sound Health Care System, Seattle, WA 98108, United States of America</aff><aff id="A5"><label>e</label> Department of Psychiatry and Behavioral Sciences, University of Washington School of Medicine, Seattle, WA 98195, United States of America</aff><author-notes><corresp id="CR1"><label>*</label> Corresponding author at: Department of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles, Semel Institute for Neuroscience and Human Behavior, 10911 Weyburn Avenue, Suite 200, Los Angeles, CA 90024, United States of America. <email>yhser@mednet.ucla.edu</email> (Y.-I. Hser).</corresp><fn fn-type="COI-statement" id="FN1"><p id="P29">Declaration of competing interest</p><p id="P30">Authors disclosing relevant financial interests, activities, relationships, and affiliations are: A.J.S. receives royalties as a section editor for UpToDate, received travel support from Alkermes, Inc. and consultant fees from Indivior, Inc. L.J.M. receives research support from Aelis Pharma. All other authors report no financial or other possible conflicts of interest.</p></fn></author-notes><pub-date pub-type="ppub"><month>3</month><year>2024</year></pub-date><pub-date pub-type="epub"><day>12</day><month>12</month><year>2023</year></pub-date><volume>158</volume><issue-id pub-id-type="pmc-issue-id">473877</issue-id><fpage>209269</fpage><lpage>209269</lpage><pub-history><event event-type="nihms-submitted"><date><day>24</day><month>10</month><year>2024</year></date></event><event event-type="pmc-release"><date><day>30</day><month>10</month><year>2024</year></date></event><event event-type="pmc-live"><date><day>30</day><month>10</month><year>2024</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-10-31 09:25:50.417"><day>31</day><month>10</month><year>2024</year></date></event></pub-history><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="nihms-2028715.pdf"/><abstract id="ABS1"><sec id="S1"><title>Background:</title><p id="P1">Co-occurring substance use disorders (SUDs) among individuals with opioid use disorder (OUD) are associated with additional impairment, overdose, and death. This study examined characteristics of patients who have OUD with and without co-occurring SUDs in rural primary care clinics.</p></sec><sec id="S2"><title>Methods:</title><p id="P2">Secondary analysis used electronic health record (EHR) data from six rural primary care clinics, including demographics, diagnoses, encounters, and prescriptions of medication for OUD (MOUD), as well as EHR data from an external telemedicine vendor that provided MOUD to some clinic patients. The study population included all adult patients who had a visit to the participating clinics from October 2019 to January 2021.</p></sec><sec id="S3"><title>Results:</title><p id="P3">We identified 1164 patients with OUD; 72.6 % had OUD only, 11.5 % had OUD and stimulant use disorder (OUD + StUD), and 15.9 % had OUD and other non-stimulant substance use disorder (OUD + Other). The OUD + StUD group had the highest rates of hepatitis C virus (25.4 % for OUD + StUD, 17.8 % for OUD + Other, and 7.5 % for OUD Only; <italic toggle="yes">p</italic> &lt; 0.001) and the highest rates of mental health disorders (78.4 %, 69.7 %, and 59.9 %, respectively; <italic toggle="yes">p</italic> &lt; 0.001). Compared to the OUD Only group, patients in the OUD + StUD and OUD + Other groups were more likely to receive telehealth services provided by clinic staff, in-clinic behavioral health services, and in-clinic MOUD. The OUD + StUD group had the highest proportion of referrals to the external telemedicine vendor.</p></sec><sec id="S4"><title>Conclusions:</title><p id="P4">More than 27 % of patients with OUD in rural primary care clinics had other co-occurring SUDs, and these patients received more healthcare services than those with OUD only. Future studies should examine variations in outcomes associated with these other services among patients with OUD and co-occurring SUDs.</p></sec></abstract><kwd-group><kwd>Opioid use disorder</kwd><kwd>Substance use disorders</kwd><kwd>Comorbidity</kwd><kwd>Health service</kwd><kwd>Rural</kwd><kwd>Primary care clinic</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front></article></pmc-articleset>